Skip to main content
Erschienen in: Zeitschrift für Gerontologie und Geriatrie 4/2011

01.08.2011 | Original Contribution

Handgrip strength measurement as a predictor for successful dry powder inhaler treatment

Application in older individuals with COPD

verfasst von: Dr. H. Frohnhofen, O. Hagen

Erschienen in: Zeitschrift für Gerontologie und Geriatrie | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

More than 10% of elderly people suffer from chronic obstructive pulmonary disease (COPD). Drug treatment for COPD involves inhalants. Dry powder inhalers (DPIs) have proven easiest for the elderly to use. Their effectiveness is dependent, however, on the inspiratory flow which can be generated, and it is unclear which geriatric assessment parameter permits inspiratory flow to be assessed.

Methods

In a randomly generated group of geriatric hospital patients, manual strength was measured as a complement to basic geriatric assessment and inspiratory flow assessed using a Turbohaler trainer.

Results

A total of 87 (27%) men (mean age 81±7 years) and 231 (73%) women (mean age 82±8 years) were included in the study. The threshold value of 40 l/min for minimum inspiratory flow was achieved by 194 (61%) of the patients. Manual strength was the only assessment parameter to correlate with the minimum inspiratory flow achieved. ROC analysis produced a threshold value for manual strength of 10 kg. The sensitivity and specificity for this threshold value were 70% each, while the positive and negative predictive values were 79% and 84%, respectively.

Conclusion

A threshold value of 10 kg for manual strength enables the inspiratory flow achievable by elderly patients to be predicted satisfactorily. This is the only parameter which correlates sufficiently with inspiratory flow. Manual strength should be measured in all geriatric patients with COPD and should be taken into account when deciding whether or not to initiate differential treatment.
Literatur
2.
Zurück zum Zitat Barnes PJ (2008) Future treatments for chronic obstructive pulmonary disease and its comorbidities. Proc Am Thorac Soc 5:857–864PubMedCrossRef Barnes PJ (2008) Future treatments for chronic obstructive pulmonary disease and its comorbidities. Proc Am Thorac Soc 5:857–864PubMedCrossRef
3.
Zurück zum Zitat Behrendt CE (2005) Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles. Chest 128:1239–1244PubMedCrossRef Behrendt CE (2005) Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles. Chest 128:1239–1244PubMedCrossRef
4.
Zurück zum Zitat Bellia B, Pistelli R, Catalano F et al (2000) Quality control of spirometry in the elderly – the Sara study. Am J Respir Crit Care Med 161:1094–1100PubMed Bellia B, Pistelli R, Catalano F et al (2000) Quality control of spirometry in the elderly – the Sara study. Am J Respir Crit Care Med 161:1094–1100PubMed
5.
Zurück zum Zitat Bellia V, Battaglia S, Matera MG, Cazzola M (2006) The use of bronchodilators in the treatment of airway obstruction in elderly patients. Pulm Pharmacol Ther 19:311–319PubMedCrossRef Bellia V, Battaglia S, Matera MG, Cazzola M (2006) The use of bronchodilators in the treatment of airway obstruction in elderly patients. Pulm Pharmacol Ther 19:311–319PubMedCrossRef
6.
Zurück zum Zitat Bhatt NY, Wood KL (2008) What defines abnormal lung function in older adults with chronic obstructive pulmonary disease? Drugs Aging 25:717–728PubMedCrossRef Bhatt NY, Wood KL (2008) What defines abnormal lung function in older adults with chronic obstructive pulmonary disease? Drugs Aging 25:717–728PubMedCrossRef
7.
Zurück zum Zitat Black LF, Hyatt RE (1969) Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 99:696–702PubMed Black LF, Hyatt RE (1969) Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 99:696–702PubMed
8.
Zurück zum Zitat Board M, Allen SC (2006) A simple test drawing test to identify patients who are unlikely to be able to learn to use an inhaler. Clinical practice 60:510–513CrossRef Board M, Allen SC (2006) A simple test drawing test to identify patients who are unlikely to be able to learn to use an inhaler. Clinical practice 60:510–513CrossRef
9.
Zurück zum Zitat Buist AS, McBurnie MA, Vollmer WM et al (2007) International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 370:741–750PubMedCrossRef Buist AS, McBurnie MA, Vollmer WM et al (2007) International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 370:741–750PubMedCrossRef
10.
Zurück zum Zitat Carvahaes-Neto N, Lorino H, Gallinari C et al (1995) Cognitive function and assessment of lung function in the elderly. Am J Respir Crit Care Med 152:1611–1615 Carvahaes-Neto N, Lorino H, Gallinari C et al (1995) Cognitive function and assessment of lung function in the elderly. Am J Respir Crit Care Med 152:1611–1615
11.
Zurück zum Zitat Celli BR, MacNee W (2004) ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23:932–946PubMedCrossRef Celli BR, MacNee W (2004) ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 23:932–946PubMedCrossRef
12.
Zurück zum Zitat Cydulkla RK, McFadden ER, Emerman CL et al (1999) Patterns of hospitalization in elderly patients with asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 156:1807–1812 Cydulkla RK, McFadden ER, Emerman CL et al (1999) Patterns of hospitalization in elderly patients with asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 156:1807–1812
13.
Zurück zum Zitat De Bisschop C, Marty ML, Tessier JF t al (2005) Expiratory flow limitation and obstruction in the elderly. Eur Respir J 26:594–601CrossRef De Bisschop C, Marty ML, Tessier JF t al (2005) Expiratory flow limitation and obstruction in the elderly. Eur Respir J 26:594–601CrossRef
14.
Zurück zum Zitat De Boer AH, Gjaltema D, Hagedoorn P (1996) Inhalation characteristics and their effect on in vitro drug delivery from dry powder inhalers. Part 2: effect of peak flow rate (PIFR) and inspiration time on the in vitro drug release from three different types of commercial dry powder inhalers. Int J Pharmaceut 138:45–56CrossRef De Boer AH, Gjaltema D, Hagedoorn P (1996) Inhalation characteristics and their effect on in vitro drug delivery from dry powder inhalers. Part 2: effect of peak flow rate (PIFR) and inspiration time on the in vitro drug release from three different types of commercial dry powder inhalers. Int J Pharmaceut 138:45–56CrossRef
15.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental-state: a practical method for grading the cognitive state of patients for clinicians. J Psych Res 12:189–198CrossRef Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental-state: a practical method for grading the cognitive state of patients for clinicians. J Psych Res 12:189–198CrossRef
16.
Zurück zum Zitat (n a) (n d) Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease 2009. Global initiative for chronic obstructive lung disease (GOLD) http://www.goldcopd.com (n a) (n d) Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease 2009. Global initiative for chronic obstructive lung disease (GOLD) http://​www.​goldcopd.​com
17.
Zurück zum Zitat Gonneratne N, Patel NP, Corcoran A (2010) Chronic obstructive pulmonary disease and management in older adults. J Am Ger Soc 58:1153–1162CrossRef Gonneratne N, Patel NP, Corcoran A (2010) Chronic obstructive pulmonary disease and management in older adults. J Am Ger Soc 58:1153–1162CrossRef
18.
Zurück zum Zitat Halbert RJ, Natoli JL, Gano A et al (2006) Global burden of COPD: systematic review and meta-analysis. Eur Respir J 28:523–532PubMedCrossRef Halbert RJ, Natoli JL, Gano A et al (2006) Global burden of COPD: systematic review and meta-analysis. Eur Respir J 28:523–532PubMedCrossRef
19.
Zurück zum Zitat Hansen-Flaschen J (2004) Chronic obstructive pulmonary disease: the last year of life. Respir Care 49:90–97 discussion 97–98PubMed Hansen-Flaschen J (2004) Chronic obstructive pulmonary disease: the last year of life. Respir Care 49:90–97 discussion 97–98PubMed
20.
Zurück zum Zitat Hardie JA, Buist AS, Vollmer WM et al (2002) Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 20:1117–1122PubMedCrossRef Hardie JA, Buist AS, Vollmer WM et al (2002) Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 20:1117–1122PubMedCrossRef
21.
Zurück zum Zitat Hardie JA, Vollmer WM, Buist AS et al (2005) Respiratory symptoms and obstructive pulmonary disease in a population aged over 70 years. Respir Med 99:186–195PubMedCrossRef Hardie JA, Vollmer WM, Buist AS et al (2005) Respiratory symptoms and obstructive pulmonary disease in a population aged over 70 years. Respir Med 99:186–195PubMedCrossRef
22.
Zurück zum Zitat Jarvis S, Ind PW, Shiner RJ (2007) Inhaled therapy in elderly COPD patients; time for re-evaluation? Age Ageing 36:213–218PubMedCrossRef Jarvis S, Ind PW, Shiner RJ (2007) Inhaled therapy in elderly COPD patients; time for re-evaluation? Age Ageing 36:213–218PubMedCrossRef
23.
Zurück zum Zitat Kleerup E (2007) Quality indicators for the care of chronic obstructive pulmonary disease in vulnerable elders. J Am Ger Soc 55:S270–S276CrossRef Kleerup E (2007) Quality indicators for the care of chronic obstructive pulmonary disease in vulnerable elders. J Am Ger Soc 55:S270–S276CrossRef
24.
Zurück zum Zitat Mahoney F, Barthel D (1965) Functional evaluation: the Barthel Index. Maryland State Med J 14:56–61 Mahoney F, Barthel D (1965) Functional evaluation: the Barthel Index. Maryland State Med J 14:56–61
25.
Zurück zum Zitat Mannino DM, Sonia Buist A, Vollmer WM (2007) Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax 62:237–241PubMedCrossRef Mannino DM, Sonia Buist A, Vollmer WM (2007) Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? Thorax 62:237–241PubMedCrossRef
26.
Zurück zum Zitat Mannino DM (2002) COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 121(Suppl 5):121S–126SPubMedCrossRef Mannino DM (2002) COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 121(Suppl 5):121S–126SPubMedCrossRef
27.
Zurück zum Zitat Medbø A, Melbye H (2007) Lung function testing in the elderly—can we still use FEV1/FVC<70% as a criterion of COPD? Respir Med 101:1097–1105PubMedCrossRef Medbø A, Melbye H (2007) Lung function testing in the elderly—can we still use FEV1/FVC<70% as a criterion of COPD? Respir Med 101:1097–1105PubMedCrossRef
28.
Zurück zum Zitat Ohta K, Fukuchi Y, Grouse L et al (2004) A prospective clinical study of theophylline safety in 3810 elderly with asthma or COPD. Respir Med 98:1016–1024PubMedCrossRef Ohta K, Fukuchi Y, Grouse L et al (2004) A prospective clinical study of theophylline safety in 3810 elderly with asthma or COPD. Respir Med 98:1016–1024PubMedCrossRef
29.
Zurück zum Zitat Rabell-Santacana V, Pastor-Ramon E, Pujol-Ribó J et al (2008) Inhaled drug use in elderly patients and limitations in association with geriatric assessment scores. Arch Bronconeumol 44:519–524PubMed Rabell-Santacana V, Pastor-Ramon E, Pujol-Ribó J et al (2008) Inhaled drug use in elderly patients and limitations in association with geriatric assessment scores. Arch Bronconeumol 44:519–524PubMed
30.
31.
Zurück zum Zitat Rezzoli L, Giardini G, Consonni S et al (2003) Quality of spirometric performance in older people. Age Ageing 32:43–46CrossRef Rezzoli L, Giardini G, Consonni S et al (2003) Quality of spirometric performance in older people. Age Ageing 32:43–46CrossRef
32.
Zurück zum Zitat Sheikh RL, Yesavage JA (1986) Geriatric depression scale (GDS). Clin Gerontol 5:165–173CrossRef Sheikh RL, Yesavage JA (1986) Geriatric depression scale (GDS). Clin Gerontol 5:165–173CrossRef
33.
Zurück zum Zitat Valente S, Pasciuto G, Bernabei R, Corbo GM (2010) Do we need different treatments for very elderly COPD patients? Respiration 80:357–368PubMedCrossRef Valente S, Pasciuto G, Bernabei R, Corbo GM (2010) Do we need different treatments for very elderly COPD patients? Respiration 80:357–368PubMedCrossRef
34.
Zurück zum Zitat Van Durme YM, Verhamme KM, Stijnen T et al (2009) Prevalence, incidence, and lifetime risk for the development of copd in the elderly. The rotterdam study. Chest 26:189–195 Van Durme YM, Verhamme KM, Stijnen T et al (2009) Prevalence, incidence, and lifetime risk for the development of copd in the elderly. The rotterdam study. Chest 26:189–195
Metadaten
Titel
Handgrip strength measurement as a predictor for successful dry powder inhaler treatment
Application in older individuals with COPD
verfasst von
Dr. H. Frohnhofen
O. Hagen
Publikationsdatum
01.08.2011
Verlag
Springer-Verlag
Erschienen in
Zeitschrift für Gerontologie und Geriatrie / Ausgabe 4/2011
Print ISSN: 0948-6704
Elektronische ISSN: 1435-1269
DOI
https://doi.org/10.1007/s00391-011-0222-1

Weitere Artikel der Ausgabe 4/2011

Zeitschrift für Gerontologie und Geriatrie 4/2011 Zur Ausgabe

Mitteilungen des BV Geriatrie

Mitteilungen des BV Geriatrie

Beiträge zum Themenschwerpunkt

Pneumonie im Alter

Medien

Medien

Mitteilungen der DGGG

Mitteilungen DGGG